Bioxytran, Inc SEC filings BIXT
Bioxytran, Inc has 470 filings in SEC EDGAR's recent list, going back to Oct 31, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 12, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2025 | — |
| DEL AM | Filing | Jan 23, 2025 | — |
| RW | Filing | Jul 8, 2024 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 28, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2023 | — |
| DEL AM | Filing | Sep 21, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| EFFECT | Filing | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2023 | — |
| D | Filing | Mar 13, 2023 | — |
| RW | Filing | Mar 2, 2023 | — |
| RW | Filing | Sep 23, 2022 | — |
| RW WD | Filing | Sep 22, 2022 | — |
| D | Filing | Aug 16, 2022 | — |
| NT 10-Q | Form 12b-25 | May 16, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Mar 29, 2022 | Dec 31, 2021 |
| RW | Form rw | Feb 28, 2022 | — |
| D | Filing | Jan 13, 2022 | — |
| NT 10-Q | Filing | Nov 12, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Jul 23, 2021 | — |
| CORRESP | Letter to the SEC | Jul 22, 2021 | — |
| D | Filing | Jul 20, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2021 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2021 | Dec 31, 2020 |
| D | Filing | Nov 5, 2019 | — |
| EFFECT | Filing | Feb 14, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 12, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| AW | Withdrawal of amendment to a registration statement | Feb 1, 2019 | — |
| CORRESP | Letter to the SEC | Jan 30, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2018 | — |
| D | Filing | Nov 6, 2018 | — |
| SC 14F1 | Schedule 14f-1 | Oct 3, 2018 | — |
| NT 10-Q | Notification of late filing | Nov 15, 2016 | Sep 30, 2016 |
| UPLOAD | Letter from the SEC | Sep 23, 2016 | — |
| CORRESP | Letter to the SEC | Sep 20, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2016 | — |
| NT 10-Q | Notification of late filing | Aug 15, 2016 | Jun 30, 2016 |
| NT 10-K | Notification of late filing | Mar 30, 2016 | Dec 31, 2015 |
| NT 10-Q | Notification of late filing | Aug 13, 2015 | Jun 30, 2015 |
| NT 10-Q | Notification of late filing | May 14, 2015 | Mar 31, 2015 |
| NT 10-K | Filing | Mar 27, 2015 | Dec 31, 2014 |
| PRER14C | U. s. rare earth minerals, inc. form prer 14c | Feb 26, 2015 | — |
| NT 10-K | 10k extension | Mar 27, 2014 | Dec 31, 2013 |
| NT 10-Q | Form 12b-25 | Nov 14, 2013 | Sep 30, 2013 |
| NT 10-Q | Quarterly report | Aug 15, 2013 | Jun 30, 2013 |
| NT 10-K | Form 10k extension | Mar 28, 2013 | Dec 31, 2012 |
| UPLOAD | Letter from the SEC | Feb 5, 2013 | — |
| CORRESP | Letter to the SEC | Dec 20, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2012 | — |
| 8-A12B | Form 8-a | Jan 5, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2009 | — |
| NT 10-Q | Filing | May 15, 2009 | Mar 31, 2009 |
| EFFECT | Filing | Apr 10, 2009 | — |
| CORRESP | Letter to the SEC | Apr 8, 2009 | — |
| CORRESP | Letter to the SEC | Apr 6, 2009 | — |
| CORRESP | Letter to the SEC | Apr 6, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2009 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2009 | — |
| CORRESP | Letter to the SEC | Jan 16, 2009 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2008 | — |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIXT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Needham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1445815
- Former names
- U.S. RARE EARTH MINERALS, INC. (until Oct 30, 2018); U.S. RARE EARTH MINERALS, INC (until Oct 3, 2018); U.S. Natural Nutrients & Minerals, Inc. (until Apr 14, 2011); AMERICA'S DRIVING RANGES, INC. (until Oct 29, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.